Cleared Traditional

K133540 - FLOCAP

K133540 is an FDA 510(k) clearance for FLOCAP, manufactured by Maxtec, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 130-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
130d
Days
Class 2
Risk

K133540 is an FDA 510(k) clearance for the FLOCAP. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Maxtec, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on March 28, 2014 after a review of 130 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Maxtec, Inc. devices

FDA 510(k) Submission Details - K133540

510(k) Number K133540 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2013
Decision Date March 28, 2014
Days to Decision 130 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 140d · This submission: 130d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 180
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K133540.
SOFTECH Plus ETCO2 Cannula
K143469 · Teleflexmedical, Inc. · Feb 2015
CAPNOSTREAM20P WITH HIFI C02 MONITORING
K123690 · Oridion Medical 1987 , Ltd. · Aug 2014
SOFTECH PLUS ETC02 CANNULA
K132946 · Teleflexmedical, Inc. · Jun 2014
MICROSTREAM FILTERLINE ICU
K121927 · Oridion Medical 1987 , Ltd. · Nov 2012
CAPNOSTREAM20P WITH AI/ODI
K112368 · Oridion Medical 1987 , Ltd. · Jul 2012
END TIDAL CO2 NASAL CANNULA
K120518 · Care Fusion · May 2012